RT Journal Article
SR Electronic
T1 Associations of the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) Cancer Prevention Recommendations with Stages of Colorectal Carcinogenesis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.01.24.23284936
DO 10.1101/2023.01.24.23284936
A1 Kværner, Ane Sørlie
A1 Andersen, Astrid Riseth
A1 Henriksen, Hege Berg
A1 Knudsen, Markus
A1 Wetting Johansen, Anne Marte
A1 Hjartåker, Anette
A1 Bøhn, Siv Kjølsrud
A1 Paur, Ingvild
A1 Wiedswang, Gro
A1 Smeland, Sigbjørn
A1 Rounge, Trine B.
A1 Blomhoff, Rune
A1 Berstad, Paula
YR 2023
UL http://medrxiv.org/content/early/2023/01/28/2023.01.24.23284936.abstract
AB While adherence to cancer prevention recommendations is linked to lower risk of colorectal cancer (CRC), few have studied associations across the entire spectrum of colorectal carcinogenesis. Here, we studied the relationship of the standardized 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Score for cancer prevention recommendations with colorectal carcinogenesis in a cross-sectional setting. Baseline data from two studies was combined to measure adherence to the seven-point 2018 WCRF/AICR Score in screening participants with a positive faecal immunochemical test and CRC patients in an intervention study. Dietary intake, body fatness and physical activity were assessed using self-administered questionnaires. Multinomial logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for screen-detected colorectal lesions and CRC. Of 1,914 participants, 548 were free from adenomas, 524 had non-advanced adenomas, 349 had advances lesions and 493 had CRC (63 screen-detected and 430 recruited from the intervention study). Adherence to the 2018 WCRF/AICR Score was inversely associated with advanced colorectal lesions; OR 0.82 (95% CI 0.71, 0.94, ptrend 0.005) per score point, but not CRC. Adherence to the alcohol recommendation was the single factor most strongly inversely associated with CRC development, being significantly associated with advanced colorectal lesions and CRC. Adherence to the 2018 WCRF/AICR cancer prevention recommendations was associated with lower probability of screen-detected advanced colorectal lesions, but not CRC. Taking a holistic approach to cancer prevention is important to prevent the occurrence of precancerous colorectal lesions.What’s new?While several studies have documented an association between adherence to cancer prevention recommendations and risk colorectal cancer, data is sparse when it comes to the precancerous lesions. In this study, including participants representing the entire spectrum of colorectal carcinogenesis, strong inverse associations were observed between adherence to the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) and the two main precursor lesion types (advanced adenoma and advanced serrated lesion), highlighting the importance of adopting a healthy lifestyle early on to prevent the development of colorectal cancer.Trial Registration ClinicalTrials.gov Identifier: NCT01538550 (Bowel Cancer Screening in Norway (BCSN) trial) and NCT01570010 (CRC-NORDIET).Competing Interest StatementRune Blomhoff is a shareholder of Vitas, Oslo, Norway. The other authors declare no potential conflicts of interest.Funding StatementThe CRCbiome study has received funding from the Norwegian Cancer Society (Grant no.: 190179), the Norwegian Cancer Societys umbrella organization for cancer research (Kreftforeningens paraplystiftelse for kreftforskning) and the Research Council of Norway (Grant no.: 280667). The CRC-NORDIET study is funded by the Throne Holst Foundation of Nutrition Research, the Norwegian Cancer Society, the Research Council of Norway and the South Eastern Norway Regional Health Authority.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The BCSN and the CRCbiome study have been approved by the Regional Committee for Medical Research Ethics in South East Norway (Approval no.: 2011/1272 and 63148, respectively). The CRC-NORDIET study has been approved by the Regional Committee for Medical Research Ethics in South East Norway (Approval no.:2011/836).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data generated in the two studies are not publicly available due to the principles and conditions set out in articles 6 [1] (e) and 9 [2] (j) of the General Data Protection Regulation (GDPR), but are available upon reasonable request from the principles investigators: CRCbiome; Paula Berstad and Trine B. Rounge (crcbiome{at}kreftregisteret.no), CRC-NORDIET; Rune Blomhoff (rune.blomhoff{at}medisin.uio.no).AICRAmerican Institute for Cancer ResearchBCSNBowel Cancer Screening in NorwayCRCColorectal cancerFFQFood frequency questionnaireFITFecal immunochemical test (FIT)ICDInternational classification of diseasesLDQLifestyle- and demograpxhics questionnaireKBSKostberegningssystem (“Dietary calculation system”)NCTNational clinical trialWCRFWorld Cancer Research Fund